Insider Trading activities of Jounce Therapeutics, Inc. insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Jounce Therapeutics, Inc. since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Jounce Therapeutics, Inc. since year 2005. Table 2 shows the detailed insider transactions of Jounce Therapeutics, Inc. since 2005. The reporting company's ticker symbol is JNCE. The reporting company's CIK number is 1640455.
The total value of stock buying since 2005 is $10,187,200.
The total value of stock sales since 2005 is $0.
The total value of stock option exercises since 2005 is $0.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Jounce Therapeutics, Inc. (JNCE).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2017-02 636,700 $10,187,200 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Jounce Therapeutics, Inc. insiders (JNCE)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-02-01 Higgons John Duncan (Director) Buy 6,700 16.00 107,200
2017-02-01 Karsen Perry A (Director) Buy 5,000 16.00 80,000
2017-02-01 Celgene Corp /de/ (10% Owner) Buy 625,000 16.00 10,000,000

Insider trading activities including stock purchases, stock sales, and option exercises of JNCE listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Jounce Therapeutics, Inc. (symbol JNCE, CIK number 1640455) see the Securities and Exchange Commission (SEC) website.